Prevalence trends of type 2 diabetes treatment, dyslipidemia and hepatic steatosis in Northeast Germany.

MLA

Bashir, Aqsa, et al. “Prevalence Trends of Type 2 Diabetes Treatment, Dyslipidemia and Hepatic Steatosis in Northeast Germany.” Journal of Public Health (Oxford, England), Nov. 2024. EBSCOhost, https://doi.org/10.1093/pubmed/fdae302.

APA

Bashir, A., Völzke, H., Henck, V., Schipf, S., Dörr, M., Nauck, M., Schmidt, C. O., Aghdassi, A., Khattak, M. N. K., Markus, M. R. P., & Ittermann, T. (2024). Prevalence trends of type 2 diabetes treatment, dyslipidemia and hepatic steatosis in Northeast Germany. Journal of Public Health (Oxford, England). https://doi.org/10.1093/pubmed/fdae302

Chicago

Bashir, Aqsa, Henry Völzke, Vivien Henck, Sabine Schipf, Marcus Dörr, Matthias Nauck, Carsten Oliver Schmidt, et al. 2024. “Prevalence Trends of Type 2 Diabetes Treatment, Dyslipidemia and Hepatic Steatosis in Northeast Germany.” Journal of Public Health (Oxford, England), November. doi:10.1093/pubmed/fdae302.